share_log

Insider Sale: Director at $SKWD (SKWD) Sells 33,539 Shares

Quiver Quantitative ·  Dec 3, 2024 05:33

James Charles Hays, a director at $SKWD ($SKWD), sold 33,539 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.2% of their shares. Following this trade, they now own 772,261 shares of $SKWD stock.

$SKWD Insider Trading Activity

$SKWD insiders have traded $SKWD stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here's a breakdown of recent trading of $SKWD stock by insiders over the last 6 months:

  • JAMES CHARLES HAYS sold 33,539 shares.
  • KIRBY HILL (PRESIDENT - INDUSTRY SOLUTIONS) sold 3,600 shares.
  • KATHARINE TERRY sold 1,653 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$SKWD Hedge Fund Activity

We have seen 109 institutional investors add shares of $SKWD stock to their portfolio, and 90 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • PRICE T ROWE ASSOCIATES INC /MD/ added 687,305 shares (+886.8%) to their portfolio in Q3 2024
  • CITADEL ADVISORS LLC added 316,985 shares (+inf%) to their portfolio in Q3 2024
  • AMERIPRISE FINANCIAL INC removed 266,749 shares (-27.5%) from their portfolio in Q3 2024
  • ROYAL BANK OF CANADA added 237,854 shares (+917.0%) to their portfolio in Q3 2024
  • VOYA INVESTMENT MANAGEMENT LLC removed 237,064 shares (-37.9%) from their portfolio in Q3 2024
  • NUVEEN ASSET MANAGEMENT, LLC removed 205,397 shares (-46.2%) from their portfolio in Q3 2024
  • MORGAN STANLEY added 201,126 shares (+24.6%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment